By Exec Edge Editorial Staff Behind every scientific breakthrough at Colossal Biosciences stands a question that transcends ...

Call them dire wolves. Don’t call them dire wolves. Colossal Biosciences, the biotechnology company from Dallas, Texas, that wants to de-extinct the woolly mammoth and dodo, doesn’t care what you call ...

When Game of Thrones premiered in 2011, one of its most unforgettable images appeared almost immediately: a litter of ...

The headlines and TV chyrons delivered the breathless news: The dire wolves had returned. It was kind of thrilling, even if you were not a fan of “Game of Thrones” where the creatures were a baleful ...

So, Colossal Biosciences — the company that’s somehow worth a casual $10.2 billion without delivering any real de-extinction success — announced they’ve “brought back” the dire wolf. A slow clap from ...

Biotechnology company Colossal Biosciences used genetic editing techniques to alter 20 genes of gray wolves (pictured above) to express certain characteristics of ancient dire wolves. The company says ...

The treatment targets and stops production of abnormal huntingtin proteins responsible for disease progression. Delivered ...

The industry’s pawprints are all over the buzzy de-extincted canine, with famous investors including Peter Jackson and George R.R. Martin. But was it all for show? By Degen Pener Deputy Editor ...

Have you been hearing about the dire wolf lately? Maybe you saw a massive white wolf on the cover of Time magazine or a photo of “Game of Thrones” author George R.R. Martin holding a puppy named after ...